136 related articles for article (PubMed ID: 15502412)
1. Consideration of cysteine protease activity for serological M-typing of clinical Streptococcus pyogenes isolates.
Morita M; Ikebe T; Watanabe H
Microbiol Immunol; 2004; 48(10):779-82. PubMed ID: 15502412
[TBL] [Abstract][Full Text] [Related]
2. The M protein is dispensable for maturation of streptococcal cysteine protease SpeB.
Zimmerlein B; Park HS; Li S; Podbielski A; Cleary PP
Infect Immun; 2005 Feb; 73(2):859-64. PubMed ID: 15664926
[TBL] [Abstract][Full Text] [Related]
3. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases.
Kansal RG; McGeer A; Low DE; Norrby-Teglund A; Kotb M
Infect Immun; 2000 Nov; 68(11):6362-9. PubMed ID: 11035746
[TBL] [Abstract][Full Text] [Related]
4. Similar superantigen gene profiles and superantigen activity in norwegian isolates of invasive and non-invasive group a streptococci.
Michaelsen TE; Andreasson IK; Langerud BK; Caugant DA
Scand J Immunol; 2011 Nov; 74(5):423-9. PubMed ID: 21707691
[TBL] [Abstract][Full Text] [Related]
5. Endopeptidase PepO Regulates the SpeB Cysteine Protease and Is Essential for the Virulence of Invasive M1T1 Streptococcus pyogenes.
Brouwer S; Cork AJ; Ong CY; Barnett TC; West NP; McIver KS; Walker MJ
J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378883
[No Abstract] [Full Text] [Related]
6. The emm-Cluster Typing System.
Smeesters PR; Botteaux A
Methods Mol Biol; 2020; 2136():25-31. PubMed ID: 32430811
[TBL] [Abstract][Full Text] [Related]
7. Description of the Pathogenic Features of Streptococcus pyogenes Isolates from Invasive and Non-Invasive Diseases in Aichi, Japan.
Matsumoto M; Yamada K; Suzuki M; Adachi H; Kobayashi S; Yamashita T; Minagawa H; Tatsuno I; Hasegawa T
Jpn J Infect Dis; 2016 Jul; 69(4):338-41. PubMed ID: 26567838
[TBL] [Abstract][Full Text] [Related]
8. emm1/sequence type 28 strains of group A streptococci that express covR at early stationary phase are associated with increased growth and earlier SpeB secretion.
Chiang-Ni C; Zheng PX; Ho YR; Wu HM; Chuang WJ; Lin YS; Lin MT; Liu CC; Wu JJ
J Clin Microbiol; 2009 Oct; 47(10):3161-9. PubMed ID: 19710271
[TBL] [Abstract][Full Text] [Related]
9. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin.
Kapur V; Topouzis S; Majesky MW; Li LL; Hamrick MR; Hamill RJ; Patti JM; Musser JM
Microb Pathog; 1993 Nov; 15(5):327-46. PubMed ID: 7516997
[TBL] [Abstract][Full Text] [Related]
10. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection.
Ashbaugh CD; Wessels MR
Infect Immun; 2001 Nov; 69(11):6683-8. PubMed ID: 11598038
[TBL] [Abstract][Full Text] [Related]
11. [M protein gene (emm) typing of Streptococcus pyogenes].
Katsukawa C; Tamaru A; Morikawa Y; Oda K
Kansenshogaku Zasshi; 2002 Apr; 76(4):238-45. PubMed ID: 12030021
[TBL] [Abstract][Full Text] [Related]
12. Application of immunoproteomics to analysis of post-translational processing of the antiphagocytic M protein of Streptococcus.
Romer TG; Boyle MD
Proteomics; 2003 Jan; 3(1):29-35. PubMed ID: 12548631
[TBL] [Abstract][Full Text] [Related]
13. Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors.
Honda-Ogawa M; Ogawa T; Terao Y; Sumitomo T; Nakata M; Ikebe K; Maeda Y; Kawabata S
J Biol Chem; 2013 May; 288(22):15854-64. PubMed ID: 23589297
[TBL] [Abstract][Full Text] [Related]
14. Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB.
Aziz RK; Pabst MJ; Jeng A; Kansal R; Low DE; Nizet V; Kotb M
Mol Microbiol; 2004 Jan; 51(1):123-34. PubMed ID: 14651616
[TBL] [Abstract][Full Text] [Related]
15. A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties.
Raeder R; Woischnik M; Podbielski A; Boyle MD
Res Microbiol; 1998 Sep; 149(8):539-48. PubMed ID: 9795991
[TBL] [Abstract][Full Text] [Related]
16. Group A streptococcal cysteine protease cleaves epithelial junctions and contributes to bacterial translocation.
Sumitomo T; Nakata M; Higashino M; Terao Y; Kawabata S
J Biol Chem; 2013 May; 288(19):13317-24. PubMed ID: 23532847
[TBL] [Abstract][Full Text] [Related]
17. Role of M3 protein in the adherence and internalization of an invasive Streptococcus pyogenes strain by epithelial cells.
Eyal O; Jadoun J; Bitler A; Skutelski E; Sela S
FEMS Immunol Med Microbiol; 2003 Oct; 38(3):205-13. PubMed ID: 14522456
[TBL] [Abstract][Full Text] [Related]
18. Emergence of type I restriction modification system-negative emm1 type Streptococcus pyogenes clinical isolates in Japan.
Okada R; Matsumoto M; Zhang Y; Isaka M; Tatsuno I; Hasegawa T
APMIS; 2014 Oct; 122(10):914-21. PubMed ID: 25356467
[TBL] [Abstract][Full Text] [Related]
19. Differences in virulence repertoire and cell invasive potential of group A Streptococcus emm1-2 in comparison to emm1 genotype.
Sagar V; Bergmann R; Nerlich A; McMillan DJ; Nitsche-Schmitz DP; Fulde M; Talay S; Geffers R; Hoe N; Kumar R; Rohde M; Chakraborti A; Chhatwal GS
Int J Med Microbiol; 2014 Jul; 304(5-6):685-95. PubMed ID: 24856243
[TBL] [Abstract][Full Text] [Related]
20. Variation in M protein production among Streptococcus pyogenes strains according to emm genotype.
Matsumoto M; Suzuki M; Hirose K; Hiramatsu R; Minagawa H; Minami M; Tatsuno I; Okamoto A; Ohta M; Hasegawa T
Microbiol Immunol; 2011 Jun; 55(6):379-87. PubMed ID: 21371090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
